| 臺大學術典藏 |
2021-02-02T02:21:48Z |
Author's response
|
Liou J.-M.; Lin J.-T.; Chang C.-Y.; Chen M.-J.; Lee Y.-C.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:46Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:46Z |
Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: Is therapeutic response predicted by Rome III subgroups?
|
Hsu Y.-C.; Liou J.-M.; Yang T.-H.; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; Wang H.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:44Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:43Z |
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
|
Liou J.-M.; MING-SHIANG WU; Shun C.-T.; Chiu H.-M.; Chen M.-J.; Chen C.-C.; Wang H.-P.; Lin J.-T.; Liang J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:42Z |
Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia
|
Hsu Y.-C.; Chiu H.-M.; Liou J.-M.; Chang C.-C.; Lin J.-T.; Liu H.-H.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:41Z |
Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?
|
Hsu Y.-C.; Yang T.-H.; Liou J.-M.; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; Wang H.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:40Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; MING-SHIANG WU; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:37Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:35Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:34Z |
Authors' reply
|
Liou J.-M.; Lee Y.-C.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:31Z |
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
|
Lee Y.-C.; Chiu H.-M.; Chiang T.-H.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; Fann J.C.-Y.; Yeh Y.-P.; Liao C.-S.; Hu T.-H.; Tu C.-H.; Tseng P.-H.; Chen C.-C.; Chen M.-J.; Liou J.-M.; Liao W.-C.; Lai Y.-P.; Wang C.-P.; Ko J.-Y.; Wang H.-P.; Chiang H.; Lin J.-T.; Chen H.-H.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:29Z |
Performance of a one-step fecal sample-based test for diagnosis of Helicobacter pylori infection in primary care and mass screening settings
|
Lee Y.-C.; Tseng P.-H.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Tu C.-H.; Chiang T.-H.; Chiu H.-M.; Lai C.-F.; Ho J.-C.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:28Z |
Tag single nucleotide polymorphisms of alcohol-metabolizing enzymes modify the risk of upper aerodigestive tract cancers: HapMap database analysis
|
Chung C.-S.; Lee Y.-C.; Liou J.-M.; Wang C.-P.; Ko J.-Y.; Lee J.-M.; MING-SHIANG WU; Wang H.-P. |
| 臺大學術典藏 |
2021-02-02T02:21:27Z |
Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis
|
Han M.-L.; Chen C.-C.; Kuo S.-H.; Hsu W.-F.; Liou J.-M.; MING-SHIANG WU; Wang H.-P. |
| 臺大學術典藏 |
2021-02-02T02:21:23Z |
Development of bacterial transglycosylase inhibitors as new antibiotics: Moenomycin A treatment for drug-resistant Helicobacter pylori
|
Tseng Y.-Y.; Liou J.-M.; Hsu T.-L.; Cheng W.-C.; MING-SHIANG WU; Wong C.-H. |
| 臺大學術典藏 |
2021-02-02T02:21:22Z |
Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; MING-SHIANG WU; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-02T02:21:21Z |
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
|
Cheng A.; Sheng W.-H.; Liou J.-M.; Wang H.-P.; MING-SHIANG WU; Lin J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-02T02:21:19Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:18Z |
Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance
|
Sheu B.-S.; Chiu C.-T.; Lee Y.-C.; Chang C.-Y.; Wu D.-C.; Liou J.-M.; MING-SHIANG WU; Chang W.-L.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:17Z |
Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease
|
Tseng P.-H.; Yang W.-S.; Liou J.-M.; Lee Y.-C.; Wang H.-P.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:17Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:15Z |
Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:15Z |
Mass eradication of helicobacter pylori to prevent gastric cancer: Theoretical and practical considerations
|
Lee Y.-C.; Chiang T.-H.; Liou J.-M.; Chen H.-H.; MING-SHIANG WU; Graham D.Y. |
| 臺大學術典藏 |
2021-02-02T02:21:15Z |
Statins and the risk of pancreatic cancer in Type 2 diabetic patients - A population-based cohort study
|
Chen M.-J.; Tsan Y.-T.; Liou J.-M.; Lee Y.-C.; MING-SHIANG WU; Chiu H.-M.; Wang H.-P.; Chen P.-C. |
| 臺大學術典藏 |
2021-02-02T02:21:14Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; Liou J.-M.; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:14Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:13Z |
letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? Authors' reply
|
Liou J.-M.; Chen M.-J.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:13Z |
Massive left pleural effusion after endoscopic variceal therapy
|
Wu W.-K.; Wang H.-P.; Liou J.-M.; MING-SHIANG WU; Chen Y.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:10Z |
Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
|
Chen P.-Y.; MING-SHIANG WU; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:09Z |
Reply to Kim J.S. and Kim B.-W.
|
Liou J.-M.; Chang C.-Y.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:08Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:08Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:07Z |
Treatment of Helicobacter pylori infection: Where are we now?
|
Liou J.-M.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:06Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; Liou J.-M.; MING-SHIANG WU; Hsu P.-N.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-02T02:21:06Z |
The Impact of Gastric Atrophy on the Incidence of Diabetes
|
Yu T.-Y.; Wei J.-N.; Kuo C.-H.; Liou J.-M.; Lin M.-S.; Shih S.-R.; Hua C.-H.; Hsein Y.-C.; Hsu Y.-W.; Chuang L.-M.; Lee M.-K.; Hsiao C.-H.; MING-SHIANG WU; Li H.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:06Z |
Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:05Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:04Z |
letter: levofloxacin resistance – a challenge for treatment of Helicobacter pylori infection. Authors' reply
|
Chen P.-Y.; MING-SHIANG WU; Liou J.-M. |
| 臺大學術典藏 |
2021-02-02T02:21:03Z |
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
|
Sheu B.-S.; MING-SHIANG WU; Chiu C.-T.; Lo J.-C.; Wu D.-C.; Liou J.-M.; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:01Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; MING-SHIANG WU; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:01Z |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|
Kuo Y.-T.; Liou J.-M.; El-Omar E.M.; Wu J.-Y.; Leow A.H.R.; Goh K.L.; Das R.; Lu H.; Lin J.-T.; Tu Y.-K.; Yamaoka Y.; MING-SHIANG WU; for the, Asian Pacific Alliance on Helicobacter; Microbiota |
| 臺大學術典藏 |
2021-02-02T02:21:00Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; MING-SHIANG WU; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-02T02:20:59Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; MING-SHIANG WU; Liou J.-M.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:20:57Z |
Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course
|
Liou J.-M.; Sheu B.-S.; Lee Y.-C.; Cheng H.-C.; Chang W.-L.; Wu D.-C.; Hsu P.-I.; Wu C.-Y.; MING-SHIANG WU; Chiu C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:20:53Z |
The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus
|
Cheng H.-C.; Liou J.-M.; Luo J.-C.; Chiu C.-T.; MING-SHIANG WU; Lee Y.-C.; Wu C.-Y.; Wu D.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Sheu B.-S. |
| 臺大學術典藏 |
2021-02-02T02:20:53Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:20:53Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:20:52Z |
Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; Fang Y.-J.; Lin J.-T.; MING-SHIANG WU; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:20:51Z |
Toward population specific and personalized treatment of Helicobacter pylori infection 11 Medical and Health Sciences 1103 Clinical Sciences
|
Liou J.-M.; Chen P.-Y.; Kuo Y.-T.; MING-SHIANG WU |
